Cita APA

COZMA, A., FODOR, A., ORASAN, O. H., VULTURAR, R., SAMPLELEAN, D., NEGREAN, V., . . . TAUT, A. S. (2019). Pharmacogenetic Implications of eNOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy. In Vivo.

Chicago Style Citation

COZMA, ANGELA, ADRIANA FODOR, OLGA HILDA ORASAN, ROMANA VULTURAR, DOREL SAMPLELEAN, VASILE NEGREAN, CRINA MURESAN, RAMONA SUHAROSCHI, i ADELA SITAR TAUT. "Pharmacogenetic Implications of ENOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy." In Vivo 2019.

Cita MLA

COZMA, ANGELA, et al. "Pharmacogenetic Implications of ENOS Polymorphisms (Glu298Asp, T786C, 4b/4a) in Cardiovascular Drug Therapy." In Vivo 2019.